A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin A in the Cheek

被引:0
|
作者
Shin, Dong Min [1 ]
Lee, Jongeun [1 ]
Noh, Hyungrye [1 ]
Jang, Donghwi [1 ]
Kim, Heeyeon [1 ]
Oh, Se Jin [1 ]
Park, Ji Hye [1 ]
Lee, Jong Hee [1 ]
机构
[1] Sungkyunkwan Univ, Dept Dermatol, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
41489
引用
收藏
页码:AB110 / AB110
页数:1
相关论文
共 50 条
  • [1] A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin A (Incobotulinum Toxin A) in the Cheek
    Shin, Dong Min
    Lee, Jongeun
    Noh, Hyungrye
    Jang, Donghwi
    Oh, Se Jin
    Park, Ji Hye
    Lee, Jong Hee
    ANNALS OF DERMATOLOGY, 2022, 34 (06) : 442 - 450
  • [2] A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin Type A 150 kD Neurotoxin in the Cheek (vol 34, pg 442, 2022)
    Shin, Dong Min
    Lee, Jongeun
    Noh, Hyungrye
    Jang, Donghwi
    Oh, Se Jin
    Park, Ji Hye
    Lee, Jong Hee
    ANNALS OF DERMATOLOGY, 2023, 35 (01) : 88 - 88
  • [3] Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study
    Choi, Jee-Woong
    Youn, Choon-Shik
    An, Hi-Tae
    Yoo, Jong-Yeop
    Na, Jung-Im
    Park, Kyoung-Chan
    Youn, Sang-Woong
    Huh, Chang-Hun
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (02) : 126 - 132
  • [4] Assessing the Efficacy and Safety of Intradermal Injection of Different Doses of Botulinum Toxin Type A: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients with Erythematic Telangiectasia
    Jiang, Yuan
    Wang, Fengyuan
    Chen, Wenqi
    Chen, Yihe
    Dai, Jie
    DERMATOLOGIC THERAPY, 2024, 2024
  • [5] The effect of botulinum toxin type a on full-face intense pulsed light treatment: A randomized, double-blind, split-face study
    Khoury, Jane G.
    Saluja, Raminder
    Goldman, Mitchel P.
    DERMATOLOGIC SURGERY, 2008, 34 (08) : 1062 - 1069
  • [6] Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema
    Kim, Min Jung
    Kim, Jin Hee
    Cheon, Hye In
    Hur, Min Seok
    Han, Song Hee
    Lee, Yang Won
    Choe, Yong Beom
    Ahn, Kyu Joong
    DERMATOLOGIC SURGERY, 2019, 45 (09) : 1155 - 1162
  • [7] Intradermal Botulinum Toxin A for Melasma: A Randomized Split-Face Study Trial and In Vitro Study of Its Antimelanogenic Effect
    Thanasarnaksorn, Wilai
    Supasiri, Thanan
    Panich, Uraiwan
    Thanachaiphiwat, Saowalak
    Salakshna, Nuntida
    DERMATOLOGIC THERAPY, 2025, 2025 (01)
  • [8] Split-face intradermal botulinum toxin versus saline injection for facial aging: a single-center study
    Elbasiony, Hala M.
    Elfar, Nashwa N.
    Gheida, Shereen F.
    Doghim, Noha N.
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2024, 21 (01): : 44 - 51
  • [9] Subcutaneous vs Intramuscular Botulinum Toxin Split-Face Randomized Study
    Gordin, Eli A.
    Luginbuhl, Adam L.
    Ortlip, Timothy
    Heffelfinger, Ryan N.
    Krein, Howard
    JAMA FACIAL PLASTIC SURGERY, 2014, 16 (03) : 193 - 198
  • [10] Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial
    Huang, Ru-Lin
    Ho, Chia-Kang
    Tremp, Mathias
    Xie, Yun
    Li, Qingfeng
    Zan, Tao
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 144 (04) : 835 - 844